최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Clinical Cancer research : an official journal of the American Association for Cancer Research, v.19 no.16, 2013년, pp.4335 - 4346
Ju, Ji-hyun (Authors' Affiliations: Department of Life Science) , Yang, Wonseok (Natural Science Institute, Hanyang University) , Lee, Kyung-min (Department of Biological Sciences, College of Biological Science and Biotechnology, Konkuk University, Seoul) , Oh, Sunhwa (and Korean BioInformation Center, KRIBB, Daejon, Republic of Korea) , Nam, KeeSoo (Authors' Affiliations: Department of Life Science) , Shim, Sarah (Natural Science Institute, Hanyang University) , Shin, Soon Young (Department of Biological Sciences, College of Biological Science and Biotechnology, Konkuk University, Seoul) , Gye, Myung Chan (and Korean BioInformation Center, KRIBB, Daejon, Republic of Korea) , Chu, In-Sun (Authors' Affiliations: Department of Life Science) , Shin, Incheol (Natural Science Institute, Hanyang University)
Purpose: Keratin19 (KRT19) is the smallest known type I intermediate filament and is used as a marker for reverse transcriptase PCR–mediated detection of disseminated tumors. In this study, we investigated the functional analysis of KRT19 in human breast cancer.Experimental Design: Using a sh...
Nat Cell Biol Coulombe 6 699 2004 10.1038/ncb0804-699 Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds
Trends Biochem Sci Omary 31 383 2006 10.1016/j.tibs.2006.05.008 “Heads and tails” of intermediate filament phosphorylation: multiple sites and functional insights
J Clin Oncol Ignatiadis 25 5194 2007 10.1200/JCO.2007.11.7762 Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer
Clin Cancer Res Bozionellou 10 8185 2004 10.1158/1078-0432.CCR-03-0094 Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer
Ann Oncol Xenidis 14 849 2003 10.1093/annonc/mdg259 Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
Nat Cell Biol Virolle 3 1124 2001 10.1038/ncb1201-1124 The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling
EMBO J Yu 28 21 2009 10.1038/emboj.2008.238 PTEN regulation by Akt-EGR1-ARF-PTEN axis
Cell Stambolic 95 29 1998 10.1016/S0092-8674(00)81780-8 Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Cell Manning 129 1261 2007 10.1016/j.cell.2007.06.009 AKT/PKB signaling: navigating downstream
Mol Cell Chuderland 31 850 2008 10.1016/j.molcel.2008.08.007 Identification and characterization of a general nuclear translocation signal in signaling proteins
J Biol Chem Matheny 269 8176 1994 10.1016/S0021-9258(17)37177-6 The nuclear localization signal of NGFI-A is located within the zinc finger DNA binding domain
Int J Biochem Cell Biol Chen 43 905 2011 10.1016/j.biocel.2011.03.004 Nuclear import of early growth response-1 involves importin-7 and the novel nuclear localization signal serine-proline-serine
Mol Biol Cell Shin 12 3328 2001 10.1091/mbc.12.11.3328 Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1
Carcinogenesis Ju 32 1474 2011 10.1093/carcin/bgr173 CD24 enhances DNA damage-induced apoptosis by modulating NF-{kappa}B signaling in CD44-expressing breast cancer cells
Oncogene Bianco 22 2812 2003 10.1038/sj.onc.1206388 Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors
Cancer Res Munster 62 3132 2002 Degradation of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, phosphatidylinositol 3′-kinase-AKT-dependent pathway
Proc Natl Acad Sci U S A Matsuzaki 100 11285 2003 10.1073/pnas.1934283100 Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation
Cell Wang 128 129 2007 10.1016/j.cell.2006.11.039 NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
J Cell Physiol Lo 188 304 2001 10.1002/jcp.1124 Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway
Blood Guha 98 1429 2001 10.1182/blood.V98.5.1429 Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression
Clin Cancer Res Guan 11 2008 2005 10.1158/1078-0432.CCR-04-0777 Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo
Mol Carcinog Hausherr 45 302 2006 10.1002/mc.20157 Dephosphorylation of p-ERK1/2 in relation to tumor remission after HER-2 and Raf1 blocking therapy in a conditional mouse tumor model
J Biol Chem Ragione 278 23360 2003 10.1074/jbc.M300771200 p21Cip1 gene expression is modulated by Egr1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect
Cancer Res Krones-Herzig 65 5133 2005 10.1158/0008-5472.CAN-04-3742 Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53
Am J Pathol Silverman 154 665 1999 10.1016/S0002-9440(10)65312-6 Pathways of Egr-1-mediated gene transcription in vascular biology
Oncogene Sauer 29 2628 2010 10.1038/onc.2010.24 Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells
Cancer Res Choi 68 1369 2008 10.1158/0008-5472.CAN-07-5222 p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression
Ann N Y Acad Sci Shishodia 1056 206 2005 10.1196/annals.1352.010 Curcumin: getting back to the roots
J Cell Biol Caulin 149 17 2000 10.1083/jcb.149.1.17 Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis
Nature Kim 441 362 2006 10.1038/nature04659 A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth
Cell Wu 25 627 1981 10.1016/0092-8674(81)90170-7 A new small (40 kd) keratin filament protein made by some cultured human squamous cell carcinomas
J Biol Chem Fradette 273 35176 1998 10.1074/jbc.273.52.35176 The type I keratin 19 possesses distinct and context-dependent assembly properties
J Cell Sci Stone 120 3999 2007 10.1242/jcs.009241 Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization
Proteomics Zhang 5 1797 2005 10.1002/pmic.200401069 Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors
Mol Cancer Ther Zhang 7 1846 2008 10.1158/1535-7163.MCT-08-0168 Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cells
Oncogene Merkhofer 29 1238 2010 10.1038/onc.2009.410 Her2 activates NF-kappaB and induces invasion through the canonical pathway involving IKKalpha
Mol Cancer Res Mora 2 115 2004 10.1158/1541-7786.115.2.2 The cytoskeleton differentially localizes the early growth response gene-1 protein in cancer and benign cells of the prostate
Biochem J Vanhaesebroeck 346 561 2000 10.1042/bj3460561 The PI3K-PDK1 connection: more than just a road to PKB
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.